ProQR Therapeutics N.V. buy Chardan Capital
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€1.87
Performance (%)
27.17%
Price
15.07.24
€1.61
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 27.17%. This prediction currently runs until 08.11.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | - | - |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-13.44%
15.07.24
15.07.24